PAPER
7-Oxanorborna-2,5-diene Derivatives
2025
IR (neat): 3033, 2972, 2952, 1710 (broad), 1638, 1559, 1456, 1436,
1381, 1314, 1271, 1228, 1137, 1079, 928, 699 cm–1.
Methyl 3-(Benzylcarbamoyl)-1-ethyl-7-oxabicyclo[2.2.1]hept-
2-ene-2-carboxylate (28)
From amido ester 19 (159 mg, 0.51 mmol), hydrogenated for 40
min in PE. Isolated by chromatography [PE–Et2O (65:35)] as a col-
orless oil; yield: 138 mg (87%); Rf = 0.25 (PE–Et2O, 1:1).
1H NMR (250 MHz, CDCl3): δ = 1.02 (t, J = 7.5 Hz, 3 H, CH2CH3),
2.18 (q, J = 7.5 Hz) and 2.20 (q, J = 7.5 Hz) (2 H, CH2CH3), 3.63 (s,
3 H, OCH3), 5.19 (s, 2 H, OCH2Ph), 5.68 (d, J = 1.8 Hz, 1 H, H-4),
6.99 (d, J = 5.2 Hz, 1 H, H-6), 7.20 (dd, J = 5.2, 1.8 Hz, 1 H, H-5),
7.30–7.41 (m, 5 H, Ph).
13C NMR (90.6 MHz, CDCl3): δ = 8.9 (CH2CH3), 21.9 (CH2CH3),
51.9 (OCH3), 66.9 (CH2Ph), 83.2 (C-4), 98.4 (C-1), 128.2 and 128.5
(CAr-o, CAr-m), 128.3 (CAr-p), 135.1 (CAr-CH2), 144.6 (C-5, C-6),
151.0 and 156.3 (C-2, C-3), 162.1 (CO2), 165.3 (CO2).
IR (neat): 3319, 3064, 3030, 2955, 2879, 1721, 1699, 1657, 1614,
1546, 1455, 1436, 1364, 1330, 1273, 1255, 1176, 1081, 1014, 988,
936, 752, 699 cm–1.
1H NMR (360 MHz, CDCl3): δ = 0.97 (t, J = 7.4 Hz, 3 H, CH2CH3),
1.51 (ddd, J = 10.8, 8.6, 3.4 Hz, 1 H, H-6endo), 1.59 (ddd, J = 11.1,
8.5, 3.4 Hz, 1 H, H-5endo), 1.69 (ddd, J = 10.8, 8.7, 3.3 Hz, 1 H, H-
6exo), 1.92 (dq, J = 14.8, 7.4 Hz, 1 H, A part of an ABM3 system,
MS (CI/NH3): m/z (%) = 69 (5), 315 (57) [M + H]+, 332 (100) [M +
CH2CH3), 2.13 (dddd, J = 11.1, 9.4, 5.0, 3.5 Hz, 1 H, H-5exo), 2.31
(dq, J = 14.8, 7.4 Hz, 1 H, B part of an ABM3 system, CH2CH3),
3.79 (s, 3 H, OCH3), 4.45 (dd, J = 14.9, 5.4 Hz) and 4.59 (dd, J =
14.9, 6.0 Hz, 2 H,) (AB part of an ABX system, NHCH2), 5.33 (d,
J = 5.0 Hz, 1 H, H-4), 7.28–7.37 (m, 5 H, Ph), 8.62 (br s, 1 H,
CONH).
13C NMR (62.9 MHz, CDCl3): δ = 9.2 (CH2CH3), 24.7 (CH2CH3),
27.8 (C-5), 29.5 (C-6), 43.5 (NCH2Ph), 52.3 (OCH3), 80.0 (C-4),
93.4 (C-1), 127.4 (CAr-p), 127.7 and 128.6 (CAr-o, CAr-m), 137.8 and
138.2 (CArCH2, C-3), 152.0 (C-2), 161.9 and 166.3 (CONH, CO2).
MS (ES+): 91 (21), 256 (18) [MH – CH2=CH2 – MeOH]+, 288 (100)
[MH – CH2=CH2]+, 289 (14), 310 (17), 316 (7) [M + H]+, 338 (85)
[M + Na]+, 339 (13).
HRMS (ES+): m/z [M + H]+ calcd for C18H22NO4: 316.1543; found:
316.1530.
NH4]+, 333 (20).
HRMS (ES+): m/z [M + Na]+ calcd for C18H18NaO5: 337.1046;
found: 337.1040.
3-Isobutyl 2-Methyl 1-Ethyl-7-oxabicyclo[2.2.1]hepta-2,5-di-
ene-2,3-dicarboxylate (26)
From monoacid 13 (55 mg, 0.25 mmol). Colorless oil; yield: 38 mg
(55%); Rf = 0.58 (PE–Et2O, 1:1).
IR (neat): 2967, 2878, 1710 (broad), 1640, 1559, 1465, 1436, 1380,
1317, 1270, 1231, 1200, 1138, 1079, 919, 791 cm–1.
1H NMR (360 MHz, CDCl3): δ = 0.94 [d, J = 6.8 Hz, 6 H,
CH(CH3)2], 1.03 (t, J = 7.5 Hz, 3 H, CH2CH3), 1.89–2.01 [m, 1 H,
CH2CH(CH3)2], 2.13–2.26 (m, 2 H, CH2CH3), 3.83 (s, 3 H, OCH3),
3.95 [d, J = 6.5 Hz, 2 H, OCH2CH(CH3)2], 5.65 (d, J = 2.0 Hz, 1 H,
H-4), 6.99 (d, J = 5.2 Hz, 1 H, H-6), 7.18 (dd, J = 5.2, 2.0 Hz, 1 H,
H-5).
13C NMR (90.6 MHz, CDCl3): δ = 8.9 (CH2CH3), 18.9 [CH(CH3)2],
22.0 (CH2CH3), 27.7 [CH2CH(CH3)2], 52.2 (OCH3), 71.3
[OCH2CH(CH3)2], 83.3 (C-4), 98.5 (C-1), 144.74 and 144.77 (C-5,
C-6), 151.3 and 155.7 (C-2, C-3), 162.4 (CO2), 165.5 (CO2).
Methyl 3-(Cyclohexylcarbamoyl)-1-ethyl-7-oxabicyc-
lo[2.2.1]hept-2-ene-2-carboxylate (29)
From amido ester 20 (197 mg, 0.65 mmol), hydrogenated for 1.5 h
in PE. Isolated by chromatography [PE–Et2O (4:1)] as a yellow oil;
yield: 188 mg (95%); Rf = 0.23 (PE–Et2O, 1:1).
MS (CI/NH3): m/z (%) = 69 (100), 281 (64) [M + H]+, 298 (45) [M
IR (neat): 3317, 3073, 2934, 2856, 1721, 1699, 1651, 1613, 1547,
1462, 1452, 1437, 1373, 1363, 1340, 1315, 1272, 1254, 1195, 1176,
1087, 1011, 988, 891, 806, 755 cm–1.
+ NH4]+, 299 (6).
HRMS (ES+): m/z [M + Na]+ calcd for C15H20NaO5: 303.1208;
found: 303.1198.
1H NMR (360 MHz, CDCl3): δ = 0.91 (t, J = 7.4 Hz, 3 H, CH2CH3),
1.12–1.40 (m, 5 H, HCy), 1.40–1.72 (m, 6 H, H-5, H-6, H-6′ and 3
HCy), 1.77–1.92 (m, 3 H, A part of an ABM3 system of CH2CH3 and
2 HCy), 2.00–2.09 (m, 1 H, H-5′), 2.25 (dq, J = 15.0, 7.4 Hz, 1 H, B
part of an ABM3 system, CH2CH3), 3.71–3.82 (m, CHN) and 3.78
(s, OCH3) (4 H), 5.21 (d, J = 5.0 Hz, 1 H, H-4), 8.15 (br d, J = 7.5
Hz, 1 H, CONH).
13C NMR (90.6 MHz, CDCl3): δ = 9.1 (CH2CH3), 24.28 and 24.30
(CH2Cy), 24.6 (CH2Cy), 25.4 (CH2CH3), 27.7 (C-5), 29.4 (C-6), 32.3
and 32.6 (CH2Cy), 47.8 (NCH), 52.2 (OCH3), 79.8 (C-4), 93.2 (C-1),
137.4 (C-3), 152.5 (C-2), 160.8 and 166.2 (CON, CO2).
2-Ethyl 3-Methyl 1-Ethyl-7-oxabicyclo[2.2.1]hepta-2,5-diene-
2,3-dicarboxylate (27)
From monoacid 15 (145 mg, 0.61 mmol). Colorless oil; yield: 107
mg (70%); Rf = 0.40 (PE–Et2O, 1:1).
IR (neat): 2978, 1731, 1713, 1644, 1560, 1436, 1369, 1312, 1264,
1231, 1197, 1138, 1095, 1080, 1041, 900, 709 cm–1.
1H NMR (250 MHz, CDCl3): δ = 1.03 (t, J = 7.5 Hz, 3 H,
CCH2CH3), 1.34 (t, J = 7.1 Hz, 3 H, OCH2CH3), 2.09–2.31 (m, 2 H,
CCH2CH3), 3.77 (s, 3 H, OCH3), 4.30 (dq, J = 10.9, 7.1 Hz) and 4.33
(dq, J = 10.9, 7.1 Hz) (AB part of an ABX3 system, 2 H, OCH2CH3),
5.65 (d, J = 2.0 Hz, 1 H, H-4), 6.99 (d, J = 5.2 Hz, 1 H, H-6), 7.19
(dd, J = 5.2, 2.0 Hz, 1 H, H-5).
13C NMR (90.6 MHz, CDCl3): δ = 9.0 (CCH2CH3), 14.1
(OCH2CH3), 22.0 (CCH2CH3), 52.0 (OCH3), 61.4 (OCH2CH3), 83.3
(C-4), 98.4 (C-1), 144.7 and 144.8 (C-5 and C-6), 151.0 and 156.4
(C-2, C-3), 162.9 (CO2), 164.9 (CO2).
MS (ES+): 248 (3), 280 (12), 302 (17), 303 (3), 308 (5) [M + H]+,
330 (100) [M + Na]+, 331 (33), 637 (7) [2M + Na]+.
HRMS (ES+): m/z [M + Na]+ calcd for C17H25NNaO4: 330.1676;
found: 330.1690.
Methyl 1-Benzyl-3-(phenylcarbamoyl)-7-oxabicyclo[2.2.1]hept-
2-ene-2-carboxylate (30)
From amido ester 21 (327 mg, 0.91 mmol), hydrogenated for 40
min in 7:3 PE–THF. Isolated by chromatography [PE–Et2O (3:1)]
as a yellow solid; yield: 307 mg (93%); mp: 108 °C; Rf = 0.42 (PE–
Et2O, 1:1).
MS (ES+): m/z (%) = 179 (22), 275 (100) [M + Na]+, 276 (13).
HRMS (ES+): m/z [M + Na]+ calcd for C13H16NaO5: 275.0890;
found: 275.0892.
IR (ATR): 3298, 3199, 3142, 3089, 3034, 2988, 2955, 2940, 2917,
2878, 1695, 1661, 1598, 1552, 1495, 1446, 1346, 1272, 1247, 1079,
982, 757, 706 cm–1.
1H NMR (360 MHz, CDCl3): δ = 1.61 (ddd, J = 11.4, 8.7, 3.7 Hz, 1
H, H-6endo), 1.70 (ddd, J = 11.2, 8.7, 3.5 Hz, 1 H, H-5endo), 1.84 (ddd,
J = 11.4, 9.4, 3.7 Hz, 1 H, H-6exo), 2.19 (dddd, J = 11.2, 9.4, 5.0, 3.6
Hz, 1 H, H-5exo), 3.34 (d, J = 15.2 Hz) and 3.56 (d, J = 15.2 Hz) (2
Oxanorbornenes 28–32; General Procedure
A preparation of 5% Pd on BaSO4 (8 mg for 1 mmol) was added to
a 0.1 M soln of the oxanorbornadiene in PE or a PE–THF mixture,
and the mixture was stirred under H2. The solids were separated by
filtration over Clarcel Flo-M and the filtrate was concentrated to
give the crude oxanorbornene, which was purified column chroma-
tography (silica gel).
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2013, 45, 2018–2028